AzTrials
AzTrials

Medical EmergenciesNCT05729802

The Holographic Standardized Patient

A study testing HoloSIM Software via Hololens 2 and Training by Mannequin Based Simulation in people with Medical Emergencies and Educational Problems, run by Sunnybrook Health Sciences Centre at 1 site in Canada.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The current pandemic has revealed in-person simulation training and evaluation is vulnerable to disruption, and alternatives are needed which allow remote evaluation. The recently developed Microsoft Hololens headset device allows interactable holograms to be inserted into a user's workspace (mixed reality) … Read more about this study

Who is it for?
Ages 20 to 100 yearsHealthy volunteers can take part
What is being tested?
HoloSIM Software via Hololens 2 and Training by Mannequin Based Simulation
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
1 siteCanada
Study dates
1 Mar 2023to 1 Apr 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 100 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Resident or fellow level volunteers from acute care postgraduate training programs (Internal Medicine, Emergency Medicine, Anesthesiology, Critical Care Medicine at Sunnybrook Health Sciences Centre

Who cannot join

  • Unwilling to enter the study
  • Previous experience with simulator based teaching on anaphylaxis

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Canada1 site, 1 recruiting
  • Sunnybrook Health Sciences Centre

    Toronto, Ontario, M4E 3M4

    Julian R Wiegelmann, MD, 416-480-4864, julian.wiegelmann@sunnybrook.ca

    Recruiting

Other trials in Canada

About this study

Official title: The Holographic Standardized Patient: Using Mixed Reality to Reduce Barriers to Crisis

The current pandemic has revealed in-person simulation training and evaluation is vulnerable to disruption, and alternatives are needed which allow remote evaluation. The recently developed Microsoft Hololens headset device allows interactable holograms to be inserted into a user's workspace (mixed reality) - permitting the augmentation of existing clinical and training spaces with holographic (i.e. virtual) patients via the prototype HoloSIM software. This study is the first known research initiative aiming to demonstrate the feasibility and effectiveness of mixed reality for acute medicine training and assessment at a distance.

Space, time, personnel, pandemic, and cost constraints limit opportunities for high-fidelity simulation exercises for post-graduate trainees at Sunnybrook. By developing and demonstrating the effectiveness of this new training modality, increased simulation exercises will lead to a higher quality education experience, better functioning teams, and better patient outcomes.

Read the detailed description

The study is the first known research initiative aiming to demonstrate that a mixed reality simulation training and assessment modality can be implemented in different clinical contexts and can improve decision making skills and management in a complex crisis scenario.

The investigators hypothesize that a mixed reality simulation training solution is usable, feasible, and can improve decision making skills and management.

It is a two stage study: 1) iteratively develop and usability test the HoloSIM software with acute care medicine specialties at Sunnybrook, and 2) determine if the HoloSIM platform is non-inferior to the current teaching and assessment standard of high-fidelity mannequin-based crisis simulation.

The understanding is that this will be a first-of-its-kind study that will generate an accessible, easy to administer tool to educate residents and fellows. The presented HoloSIM software will allow teams to practice and assess their responses to a variety of scenarios in clinical environments such as the trauma bay and ICU. This has the potential to improve team function and enhance quality of care across the healthcare system.

Healthcare facilities without expensive simulation centres are unable to participate in high-fidelity medical simulation. Inequities in access to high quality training and professional development have been repeatedly cited as a barrier to retention of rural health care providers. The SHSC simulation centre will adapt this approach and offer training at a distance and medical crisis coaching to rural health care providers utilizing the this mentioned platform. Lastly, all simulation resources developed during the project will be made freely available via the project website. Other institutions internationally may use them to improve their team performance, patient safety, and postgraduate education programs.

Being tested
HoloSIM Software via Hololens 2, Training by Mannequin Based Simulation
Keywords
Mixed Reality, Augmented Reality, Medical Simulation, Hololens

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • HoloSIM Software via Hololens 2Device

    Participants will train via a mixed reality simulated crisis scenario using the HoloSIM software on the Microsoft Hololens 2

  • Training by Mannequin Based SimulationOther

    Participants will train a via traditional mannequin based medical crisis scenario

Study groups in NCT05729802
Study groupRoleWhat they receive
Group A: HoloSIM (intervention)ExperimentalTraining by Mixed Reality Simulation
Receives: Device: HoloSIM Software via Hololens 2
Group B: Mannequin (control)Active comparatorTraining by Mannequin Based Simulation
Receives: Other: Training by Mannequin Based Simulation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Anaphylaxis Checklist of Core Decision Making Steps

    Expert consensus based checklists of critical scenario actions on a mannequin based crisis scenario. Student scenario performance graded from 0 to 45, with higher scores representing a better performance.

    Measured: 30 days post exposure

Secondary outcomes (4)
  1. System Usability Scale (SUS)

    Likert scale (5 point) based assessment of software usability. Higher scores on a scale of 1 to 5 represent a better software system usability.

    Measured: Immediately after exposure

  2. Modified Simulation Effectiveness Tool (SET-M)

    likert scale (3 point) validated assessment of learning satisfaction tool

    Measured: Immediately after exposure

  3. Time required to complete critical crisis related tasks

    Measured time until critical scenario management events occur

    Measured: 30 days post exposure

  4. anaphylaxis knowledge test

    validated multiple choice quiz of anaphylaxis knowledge developed by allergists for use with the same curriculum included in our study

    Measured: 30 days post exposure

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Feb 2023
  2. Study start1 Mar 2023
  3. Primary completion1 Sep 2025 (estimated)
  4. Study completion1 Apr 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Model description
It is a two stage study that will: 1) iteratively develop and usability test the HoloSIM software with acute care medicine specialties at Sunnybrook, and 2) determine if the HoloSIM platform is non-inferior to the current teaching and assessment standard of high-fidelity mannequin-based crisis simulation.
Masking
None (open label)
Enrolment
40 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05729802
Sponsor's protocol ID
3777
Status last verified
Jan 2025
First submitted
6 Jan 2023
Last updated
29 Jan 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: For confidentiality purpose, Participants personal information will not be shared, and any study data that will be sent outside of the research institution will be encrypted by an ID code for each participant.

Questions about this trial

What is this clinical trial studying?

A study testing HoloSIM Software via Hololens 2 and Training by Mannequin Based Simulation in people with Medical Emergencies and Educational Problems, run by Sunnybrook Health Sciences Centre at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 29 Jan 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Anaphylaxis Checklist of Core Decision Making Steps (time frame: 30 days post exposure). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Jan 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in